Thank you, Mr. Chair.
Repeatedly throughout this meeting, the number 13 has been quoted with respect to pharmaceutical company consultations with the minister.
To either witness, do you recall anything happening across Canada last year with respect to analgesics that might have warranted some of those meetings with pharmaceutical companies? Also, are analgesics patented drugs?